Orapi SA, together with its subsidiaries, manufactures and sells professional hygiene products and industrial process products worldwide.
+ 1 more risk
Undervalued with questionable track record.
Share Price & News
How has Orapi's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ORAP's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ORAP underperformed the French Chemicals industry which returned 34.9% over the past year.
Return vs Market: ORAP underperformed the French Market which returned 15.2% over the past year.
Price Volatility Vs. Market
How volatile is Orapi's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StEvaluating Orapi SA’s (EPA:ORAP) Investments In Its Business
1 month ago | Simply Wall StDoes Orapi SA's (EPA:ORAP) CEO Salary Reflect Performance?
2 months ago | Simply Wall StOrapi (EPA:ORAP) Use Of Debt Could Be Considered Risky
Is Orapi undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ORAP (€5.7) is trading below our estimate of fair value (€26.19)
Significantly Below Fair Value: ORAP is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ORAP is good value based on its PE Ratio (8.3x) compared to the Chemicals industry average (20.9x).
PE vs Market: ORAP is good value based on its PE Ratio (8.3x) compared to the French market (18.6x).
Price to Earnings Growth Ratio
PEG Ratio: ORAP's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: ORAP is good value based on its PB Ratio (0.5x) compared to the FR Chemicals industry average (1.4x).
How is Orapi forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORAP's earnings are forecast to decline over the next 3 years (-58.9% per year).
Earnings vs Market: ORAP's earnings are forecast to decline over the next 3 years (-58.9% per year).
High Growth Earnings: ORAP's earnings are forecast to decline over the next 3 years.
Revenue vs Market: ORAP's revenue is expected to decline over the next 3 years (-1% per year).
High Growth Revenue: ORAP's revenue is forecast to decline over the next 3 years (-1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORAP is forecast to be unprofitable in 3 years.
How has Orapi performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ORAP has a large one-off gain of €2.4M impacting its June 30 2019 financial results.
Growing Profit Margin: ORAP became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: ORAP has become profitable over the past 5 years, growing earnings by -13.3% per year.
Accelerating Growth: ORAP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: ORAP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-19.4%).
Return on Equity
High ROE: ORAP's Return on Equity (6.6%) is considered low.
Return on Assets
Return on Capital Employed
How is Orapi's financial position?
Financial Position Analysis
Short Term Liabilities: ORAP's short term assets (€105.4M) exceed its short term liabilities (€95.9M).
Long Term Liabilities: ORAP's short term assets (€105.4M) exceed its long term liabilities (€67.4M).
Debt to Equity History and Analysis
Debt Level: ORAP's debt to equity ratio (155.6%) is considered high.
Reducing Debt: ORAP's debt to equity ratio has increased from 129.9% to 155.6% over the past 5 years.
Inventory Level: ORAP has a high level of physical assets or inventory.
Debt Coverage by Assets: ORAP's debt is covered by short term assets (assets are 1.4x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ORAP is profitable, therefore cash runway is not a concern.
Forecast Cash Runway: ORAP is profitable, therefore cash runway is not a concern.
What is Orapi's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ORAP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ORAP's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ORAP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ORAP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ORAP is not paying a notable dividend for the French market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ORAP's dividend in 3 years as they are not forecast to pay a notable one for the French market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Guy Chifflot 0
Mr. Monsieur Guy Chifflot serves as the Chairman, Chief Executive Officer and President of Orapi. Mr. Chifflot serves as a Manager of ORAPI Europe and Orapi International. Mr. Chifflot serves as the Managi ...
CEO Compensation Analysis
Compensation vs Market: Guy's total compensation ($USD677.82K) is above average for companies of similar size in the French market ($USD308.22K).
Compensation vs Earnings: Guy's compensation has been consistent with company performance over the past year.
|Chairman of the Board||0yrs||€624.00k||no data|
|Head of Communications & Director||0yrs||€49.34k||no data|
|Deputy CEO & Director||9.8yrs||€273.61k||no data|
|Director and Managing Director of Asia & Middle East||0yrs||€279.95k||no data|
|Independent Director||17.8yrs||€2.40k||no data|
|Independent Director||4.8yrs||€2.40k||no data|
|Independent Director||0yrs||no data||no data|
|Independent Director||0yrs||no data||no data|
Experienced Board: ORAP's board of directors are considered experienced (8.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Orapi SA's company bio, employee growth, exchange listings and data sources
- Name: Orapi SA
- Ticker: ORAP
- Exchange: ENXTPA
- Founded: 1968
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: €26.116m
- Shares outstanding: 4.58m
- Website: https://www.orapi.com
Number of Employees
- Orapi SA
- PARC INDUSTRIEL DE LA PLAINE DE L'AIN
- 225 ALLÉE DES CÈDRES
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ORAP||ENXTPA (Euronext Paris)||Yes||Ordinary Shares||FR||EUR||Apr 2000|
|0ICI||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||EUR||Apr 2000|
|ORAPP||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||EUR||Apr 2000|
Orapi SA, together with its subsidiaries, manufactures and sells professional hygiene products and industrial process products worldwide. The company provides cleaning and disinfection products, and products for equipment and machine upkeep. It serves transportation, health care, and others industries; local government; and cleaning companies and recreation/shops. The company was founded in 1968 and is based in Saint-Vulbas, France. Orapi SA is a subsidiary of Financière MG3F.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/22 21:11|
|End of Day Share Price||2020/02/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.